Toggle Offcanvas
...
 
Everolimus Tenders

Everolimus Tenders

View Everolimus tenders, RFPs and contracts. Bid on readily available Everolimus tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Everolimus tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Everolimus.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Everolimus market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Everolimus tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

22 Live Notices for Everolimus Tenders

Showing 1 to 20

Delivery Of Disposable Medical Equipment For The Needs Of The Hemodynamics Laboratory - 65 Tasks
country Poland
posting date12 Mar 2025
deadline16 Apr 2025
Everolimus Cmcm Rec 1000020754
country Chile
posting date06 Mar 2025
deadline04 Apr 2025
Purchase Of Medical Program (Medical Program Of Cardiovascular Catheterization Lab).
country Georgia
posting date04 Mar 2025
deadline21 Mar 2025
Dhs/P/Ww/141/26 - 300,000 Tablets Of Everolimus Tablets 0.25Mg
country Sri Lanka
posting date25 Feb 2025
deadline03 Apr 2025
Dhs/P/Ww/141/26 - 300,000 Tablets Of Everolimus Tablets 0.25Mg
country Sri Lanka
posting date24 Feb 2025
deadline03 Apr 2025
Medical Consumables For Cathdiology
country North Macedonia
posting date20 Feb 2025
deadline19 Mar 2025
Specific Multilot Contract, Pursuant To Art. 55 Of Legislative Decree No. 50/2016 And Ss.Mm.Ii., For The Supply Of Connected Drugs And Services
country Italy
posting date20 Feb 2025
deadline13 Mar 2025
Supply of Medicine and Medical / Surgical equipments : Everolimus Tablet 0.25mg\nEverolimus tablet 0.25mg\nEach tablet to contain 0.25mg of Everolimus.\nNote: 01.The shelf life of the product should\nbe minimum of 24 months\nPacking : 10 Tablets in a Blister\n10 Blister in a Pack etc .
country Sri Lanka
posting date20 Feb 2025
deadline03 Apr 2025
Medicines For The Treatment Of Rare Diseases In The Republic Of North Macedonia For 2025
country North Macedonia
posting date18 Feb 2025
deadline17 Mar 2025
Stent Everolimus
country Chile
posting date14 Feb 2025
deadline17 Mar 2025
Pharmaceutical Contracts With Accession Option
country Germany
posting date13 Feb 2025
deadline01 Feb 2027
Purchase And Successive Delivery Of Medicinal Products For Drug And Chemotherapy Programs
country Poland
posting date12 Feb 2025
deadline17 Mar 2025
Suminista De Stent With A Drawing Everolimus
country Chile
posting date11 Feb 2025
deadline13 Mar 2025
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
country Saudi Arabia
posting date05 Feb 2025
deadline02 Nov 2025
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
country Saudi Arabia
posting date06 Jan 2025
deadline02 Nov 2025
Open House Discount Agreements 2024-03 - Everolimus (Atc: L04Ah02; Tab)
country Germany
posting date15 Feb 2024
deadline31 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Everolimus, Atc L04Aa18 For The Period February 1St, 2024 - January 31St, 2026
country Germany
posting date18 Dec 2023
deadline05 Dec 2025
Medicines With The Active Ingredient Everolimus (Atc: L04Aa18)
country Germany
posting date12 Dec 2023
deadline30 Nov 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Everolimus (L04Aa18) As Part Of A So-Called Open House Model.
country Germany
posting date11 Oct 2023
deadline30 Sep 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Everolimus (L04Aa18) As Part Of A So-Called Open House Model.
country Germany
posting date10 Oct 2023
deadline30 Sep 2025

Share Share this page